<p>George W. Lloyd, EVP, Investments &amp; CLO of Royalty Pharma plc, reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001814899-25-000006), on November 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

RPRX

<p>George W. Lloyd, EVP of Royalty Pharma, reported the sale of common shares of the company. The information was published via EDGAR by Royalty Pharma on November 21, 2025. This brief was created by Public Technologies using AI and is for informational purposes only.</p>

Royalty Pharma EVP George W. Lloyd Reports Sale of Common Shares